Author:
Wang Ning,Drotar Dennis,Hershey Gurjit K. Khurana
Reference93 articles.
1. Aiuti, A. (2002). Advances in gene therapy for ADA-deficient SCID. Current Opinion in Molecular Therapeutics, 4, 515–522.
2. Asghari, V., Sanyal, S., Buchwaldt, S., Paterson, A., Jovanovic, V., & Van Tol, H. H. (1995). Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. Journal of Neurochemistry, 65, 1157–1165.
3. Barnes, P. J. (1995). Inhaled glucocorticoids for asthma. New England Journal of Medicine, 332, 868–875.
4. Bauman, L. J., Wright, E., Leickly, F. E., Crain, E., Kruszon-Moran, D., Wade, S. L., et al. (2002). Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics, 110, e6.
5. Bertilsson, L., Dahl, M. L., Dalen, P., & Al-Shurbaji, A. (2002). Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs. British Journal of Clinical Pharmacology, 53, 111–122.